New hope for Post-Concussion headaches: one infusion may stop chronic pain
NCT ID NCT07191145
First seen Nov 01, 2025 · Last updated Jun 10, 2026 · Updated 33 times
Summary
This study tests whether a single infusion of eptinezumab, given within 8 weeks of a mild traumatic brain injury, can reduce the number of moderate-to-severe headache days and prevent headaches from becoming chronic. About 80 adults with post-traumatic headaches that have migraine features will receive either the drug or a placebo. The goal is to see if early treatment can lower headache burden and improve recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC HEADACHE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.